Conceptions of risk in the lives of club drug-using youth

Substance Use and Misuse

Volumn 40, Issue 9-10, 2005, Pages 1443-1459

  Kelly, Brian C ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b FORDHAM UNIVERSITY   (United States)

Author keywords

Club drugs; Ecstasy; Ethnography; Folk models; Risk; Risk assessment; Risk management; Youth

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ARTICLE; COMPARATIVE STUDY; HEALTH PROMOTION; HUMAN; JUVENILE DELINQUENCY; MODEL; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED STATES;

EID: 23244431641     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.1081/JA-200066812     Document Type: Article

References (33)

1. Agar, M. (1985). Folks and professionals: Different models for the interpretation of drug use. The International Journal of the Addictions 20(1): 173-182.
2. Baggott, M., Mendelson, J. (2001). Does MDMA cause brain damage? In: Holland, J., ed. Ecstasy: The Complete Guide. Rochester, Vermont: Park Street Press.
3. Beck, J., Rosenbaum, M. (1994). Pursuit of Ecstasy: The MDMA Experience Albany, New York: SUNY Press.
4. Bluthenthal, R. N., Watters, J. K. (1995). Multimethod research from targeted sampling to HIV risk environments. NIDA Research Monograph 157:212-230.
5. Buffum, J., Moser, C. (1986). MDMA and human sexual function. Journal of Psychoactive Drugs 18(4):355-360.
6. Carlson, R., McCaughan, J. A., Falck, R. S., Wang, J., Siegal, H. A., Daniulaityte, R. (2004). Perceived adverse consequences associated with MDMA/ecstasy use among young adults in Ohio: Implications for intervention. International Journal of Drug Policy (in press).
7. Chang, L., Grob, C. S., Ernst, T., Itti, L., Mishkin, F. S., Jose-Melchor, R., Poland, R. E. (2000). Effect of ecstasy (3,4- methylenedioxymethamphetamine [MDMA]) on cerebral blood flow: A co-registered SPECT and MRI study. Psychiatry Research 98:16-28.
8. Curran, H. V., Travill, R. A. (1997). Mood and cognitive effects of 3,4-methylenedioxymetham-phetamine (MDMA, ecstasy): Weekend "high" followed by mid-week low. Addiction 92:821-831.
9. Derzon, J. H., Lipsey, M. W. (1999). What good predictors of marijuana use are good for: A synthesis of research. School Psychology International. 20(1):69-85.
10. Douglas, M. (1992). Risk and Blame: Essays in Cultural Theory. New York: Routledge.
11. Frosch, D., Shoptaw, S., Huber, A., Rawson, R. A., Ling, W. (1996). Sexual risk among gay and bisexual male methamphetamine abusers. Journal of Substance Abuse Treatment 13(6):483-486.
12. Geertz, C. (1983). Local Knowledge: Further Essays in Interpretive Anthropology. New York: Basic Books.
13. Gill, J. R., Hayes, J. A., deSouza, I. S., Marker, E., Stajic, M. (2002). Ecstasy (MDMA) deaths in New York City: A case series and review of the literature. Journal of Forensic Sciences 47(1):121-126.
14. Henry, J. A. (1992). Ecstasy and the dance of death. British Medical Journal 305:5-6.
15. Henry, J. A., Jeffreys, K. J., Dawling, S. (1992). Toxicity and deaths from 3,4 methylenedioxymetham-phetamine ("ecstasy"). Lancet 340:384-387.
16. Henry, J. A., Rella, J. (2001). Medical risks associated with MDMA use. In: Holland, J., ed. Ecstasy: The Complete Guide. Rochester, Vermont: Park Street Press.
17. Hwang, I., Daniels, A. M., Holtzmuller, K. C. (2002). "Ecstasy"-induced hepatitis in an active duty soldier. Military Medicine 167(2):155-156.
18. Jansen, K. L. R. (1998). Ecstasy (MDMA) dependence. Drug and Alcohol Dependence 53(2):121-124.
19. Jayanthi, S., Ladenheim, B., Andrews, A. M., Cadet, J. L. (1999). Overexpression of human copper/zinc superoxide dismutase in transgenic mice attenuates oxidative stress caused by methelyenedioxymethamphetamine (ecstasy). Neuroscience 91:1379-1387.
20. Leonard, L., Ross, M. (1997). The last sexual encounter: The contextualization of sexual risk be-haviour. International Journal of STD & AIDS 8:643-645.
21. Luhmann, N. (1993). Risk: A Sociological Theory. New York: De Gruyter Press.
22. Mas, M., Farre, M., de la Torre, R., Roset, P., Ortuno, J., Segura, J., Cami, J. (1999). Cardiovascular and neuroendocrine effects and pharmacokinetics of 3,4-methylenedioxymethamphetamine in humans. Journal of Pharmacology and Experimental Therapeutics 290:136-145.
23. Morgan, M. J. (1998). Recreational Use of "ecstasy" (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 19:252-264.
24. Mueller, P. D., Korey, W. S. (1998). Death by "ecstasy": The serotonin syndrome? Annals of Emergency Medicine 32:377-380.
25. O'Shea, E., Granados, R., Esteban, B., Colado, M. I., Green, A. R. (1998). The relationship between the degree on neurodigestion of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA (ecstasy). Neuropharmacology 37:919-926.
26. Parrott, A. C., Lasky, J. (1998). Ecstasy (MDMA) effects upon mood and cognition: Before, during, and after a Saturday night dance. Psychopharmacology 139(3):261-268.
27. Shankaran, M., Yamamoto, B. K., Gudelsky, G. A. (1999). Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine. European Journal of Pharmacology 385:103-110.
28. Solowij, N., Hall, W., Lee, N. (1992). Recreational MDMA use in Sydney: A profile of "ecstasy" users and their experiences with the drug. British Journal of Addiction 87:1161-1172.
29. Strauss, A., Corbin, J. (1998). Basics of Qualitative Research: Grounded Theory Procedures and Techniques. 2nd Ed. Newbury Park, CA: Sage Publications.
30. Sternbach, H. (1991). The serotonin syndrome. American Journal of Psychiatry 148:705-713.
31. Temple, M. T., Leigh, B. C., Schafer, J. (1993). Unsafe sexual behavior and alcohol use at the event level: Results of a national survey. Journal of Acquired Immune Deficiency Syndromes 6:393-401.
32. Topp, L., Hando, J., Dillon, P., Roche, A., Solowij, N. (1999). Ecstasy use in Australia: Patterns of use and associated harm. Drug & Alcohol Dependence 55(1-2):105-115.
33. Zemishlany, Z., Aizenberg, D., Weizman, A. (2001). Subjective effects of MDMA ("ecstasy") on human sexual function. European Psychiatry 16(2):127-130.